Human Leukocyte Antigen DR (HLA-DR) monoclonal antibody YAML 555.6
Hybridoma cell line producing YAML 555.6 antibodies raised against human leukocyte antigen DR (HLA-DR) which are rat monoclonal antibodies of the IgG2a isotype.
A non-exclusive licence with standard terms and conditions is available for this reagent.
To obtain a licence:
1. Download the licence document via the link and enter your company name and full registered address on page 1 of licence agreement.
2. Print two copies of the licence agreement and have both signed by an authorised official of your organisation.
3. Provide your contact details (name, job title, email, telephone and fax number) for subsequent invoicing and mail both original signed licence agreements to:
Research Reagents
Cambridge Enterprise Limited
University of Cambridge
Hauser Forum
3 Charles Babbage Road
Cambridge CB3 0GT
Publications:
Journal of Immunology Vol 134 5th May 1985 pages 3056-3061
